Formycon (FYB.DE) stock: key figures, P/E, revenue and dividend
Health Care · Germany · ISIN DE000A1EWVY8
Formycon financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 69.00 m EUR | 44.00 m EUR |
| Gross profit | 14.00 m EUR | 3.00 m EUR |
| Operating income | -23.47 m EUR | -30.46 m EUR |
| EBIT | -23.00 m EUR | -29.00 m EUR |
| Net income | -125.00 m EUR | -64.00 m EUR |
| Diluted EPS – continuing operations | -7.11 EUR | -3.66 EUR |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Formycon
Formycon AG, a biotechnology company, develops biosimilar drugs in Germany and Switzerland. It provides ranibizumab and aflibercept used in the treatment of neovascular age-related macular degeneration, diabetic macular edema, choroidal neovascularization, proliferative diabetic retinopathy, and macular edema under the Ranivisio, Ongavia, Cimerli, Ranopto, Uptera, and Ravegza brand names, as well as AHZANTIVE, Baiama, and Fovlya brand names. The company's pipeline includes ustekinumab used in the treatment of Crohn's disease, ulcerative colitis, Plaque Psoriasis, and Psoriatic Arthritis under the Otulf, Fymskina, and Sitovab brand names. It is also developing pembrolizumab for the treatment of immuno-oncology diseases, such as advanced melanoma, non-small cell bronchial carcinoma, asthma, hodgkin's lymphoma, urothelial carcinomas, tumors in the head and neck area, sinusitis with nasal polyps area, other tumor and genetic diseases; and FYB208 and FYB209 that is indicated for immunology areas. The company was formerly known as Nanohale AG and changed its name to Formycon AG in 2012. Formycon AG was founded in 1999 and is headquartered in Planegg, Germany.
More stocks
- Scribe Therapeutics Inc. Common Stock (SCTX)
- Jiang Su New Technology Co. Ltd. (301229.SZ)
- Ajinomoto Malaysia Bhd (2658.KL)
- FocalTech Systems Co Ltd (3545.TW)
- Iron Horse Acquisition II Corp. (IRHO)
- Dongwon Systems Corp (014825.KS)
- ESCALADE INC (ESCA)
- ANVI GLOBAL HOLDINGS, INC. (ANVI)
- Yunnan luoping Zinc & Electricity Co Ltd (002114.SZ)
- Shanghai Yaohua Pilkington Glass Group Co Ltd B (900918.SS)
- Nbond Nonwovens (603238.SS)
- QNB CORP. (QNBC)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.